हिंदी में पढ़ें

Cipla

Cipla shares surge nearly 10% after positive USFDA update on Goa facility

Cipla shares surge nearly 10% after positive USFDA update on Goa facility

Thu, Oct 31, 2024

USFDA's VAI classification boosts Cipla’s outlook for niche drug launches, including Abraxane generic

'Diwali Offer' Stocks by Anil Singhvi: These 2 largecap, 1 smallcap scrips can give up to 70% return - Check targets

'Diwali Offer' Stocks by Anil Singhvi: These 2 largecap, 1 smallcap scrips can give up to 70% return - Check targets

Thu, Oct 31, 2024

'Diwali Offer' Stocks by Anil Singhvi: Stock markets have been very volatile in last one month. Benchmark equity indices Sensex and Nifty fell in early trade even Thursday i.e. October 31, 2024. Amid this, investors are looking for stocks that can offer good return in long term.

Cipla Q2 earnings preview: Margins under pressure as US, domestic sales outlook remains modest

Cipla Q2 earnings preview: Margins under pressure as US, domestic sales outlook remains modest

Tue, Oct 29, 2024

Zee Business forecasts indicate a three percent year-on-year revenue increase, with Cipla’s Q2 revenue expected at Rs 6,892 crore, up from Rs 6,678 crore in the same quarter last year

TRENDING NOW

Cipla Vice Chairman MK Hamied steps down

Cipla Vice Chairman MK Hamied steps down

Tue, Sep 03, 2024

"It is with a heavy heart that I write to formally announce my resignation from the position of Vice Chairman and Non-Executive Director of the company," Cipla Vice Chairman MK Hamied wrote in a letter addressed to the board of the pharmaceutical company.

Cipla's net profit rose 17.77% in Q1; what should investors do?

Cipla's net profit rose 17.77% in Q1; what should investors do?

Mon, Jul 29, 2024

Global brokerages have revised their stance on Cipla. Cipla on Friday, during market hours, pharma major reported a 17.77 per cent rise in consolidated net profit at Rs 1,175.46 crore in the first quarter that ended June 30, 2024.

Cipla Q1 preview: Pharma major to likely report low double-digit growth in PAT; margins seen to remain steady

Cipla Q1 preview: Pharma major to likely report low double-digit growth in PAT; margins seen to remain steady

Thu, Jul 25, 2024

Cipla is likely to report its Q1 numbers later today and the Street expects the company to post good show considering the like market share gains.

Cipla receives income tax demand of Rs 773 crore

Cipla receives income tax demand of Rs 773 crore

Tue, Jul 16, 2024

According to an exchange filing, the demand covers assessment years from 2015-16 to 2022-23, following assessment and re-assessment orders issued on July 12.

Indraprastha Gas, Cipla, Prestige Estates Projects & Axis Bank, which stocks will be in focus today?

Indraprastha Gas, Cipla, Prestige Estates Projects & Axis Bank, which stocks will be in focus today?

Mon, Jun 24, 2024

Indraprastha Gas, Cipla, Prestige Estates Projects & Axis Bank, which stocks will be in focus today? News shares and triggers. Know about Stocks In News.

Cipla gets USFDA nod to market Lanreotide injection

Cipla gets USFDA nod to market Lanreotide injection

Wed, May 22, 2024

The drugmaker said its product is indicated for the treatment of patients with acromegaly and gastroenteropancreatic neuroendocrine tumours.

Cipla Block Deal: 2.52% equity changes hands in multiple block deals; shares climb 5%

Cipla Block Deal: 2.52% equity changes hands in multiple block deals; shares climb 5%

Wed, May 15, 2024

The reports suggested that the promoter group of Cipla will divest a nearly 2.53 per cent stake in the company via a block deal worth as much as Rs 2,637 crore at a per share price range of Rs 1,289.5-1,357.35.

Cipla reports a 78.7% jump in profits; what should investors do?

Cipla reports a 78.7% jump in profits; what should investors do?

Mon, May 13, 2024

Cipla share price: At around 10:12 a.m., shares of Cipla traded 5.6 per cent or Rs 75 higher at Rs 1,4145.75 apiece. The market capitalisation of the company stood at Rs 1,14,201.98 crore at around the same time.

Cipla Q4 Results: Net profit soars 79%, beats analysts' estimates

Cipla Q4 Results: Net profit soars 79%, beats analysts' estimates

Fri, May 10, 2024

Cipla Q4 Results: Pharmaceutical company Cipla reported a 78.6 per cent year-on-year jump in consolidated net profit to Rs 939 crore for the March quarter, exceeding analysts' expectations.

Cipla dividend 2024: Pharma major announces 650% final dividend - Check record date and other details

Cipla dividend 2024: Pharma major announces 650% final dividend - Check record date and other details

Fri, May 10, 2024

Cipla dividend 2024: According to the company, the dividend amount will be paid to eligible investors within 30 days from the date of the Annual General Meeting.

Cipla, Glenmark recall drugs in US due to manufacturing issues

Cipla, Glenmark recall drugs in US due to manufacturing issues

Sun, May 05, 2024

The recalled drug is used to help control the symptoms of lung diseases, including asthma, chronic bronchitis and emphysema.

5 pharma stocks that can offer up to 28% return - Check target price by ICICI Securities

5 pharma stocks that can offer up to 28% return - Check target price by ICICI Securities

Wed, Apr 17, 2024

According to ICICI Securities, these stocks can help investors get a return of up to 28 per cent in the next one year.

Cipla to acquire Ivia Beaute's cosmetics, personal care distribution and marketing biz for Rs 130 crore

Cipla to acquire Ivia Beaute's cosmetics, personal care distribution and marketing biz for Rs 130 crore

Tue, Apr 16, 2024

The acquisition will include Ivia Beaute's brands namely Astaberry, Ikin and Bhimsaini on a worldwide basis, the company said.

Sanofi India, Cipla shares rise on exclusive distribution tie-up

Sanofi India, Cipla shares rise on exclusive distribution tie-up

Wed, Mar 27, 2024

Sanofi India share price, Cipla share price: Shares of pharmaceutical companies Sanofi India and Cipla gained on Wednesday, March 27, after the firms announced an exclusive distribution tie-up for expanding the reach of Sanofi’s Central Nervous System (CNS) portfolio, including its six brands.

Pharma giant Cipla hits all-time high, stock surges over 70% in one year

Pharma giant Cipla hits all-time high, stock surges over 70% in one year

Mon, Mar 11, 2024

Cipla share price: Cipla's stock was trading up by 2.11 per cent, or Rs 31.30, at Rs 1513.25 at 10:43 am on Monday. The stock that closed at Rs 1481.95 on Friday started its trading session on Monday at Rs 1490.35.

Cipla shares trade within inches of record high; check out latest triggers for drug maker

Cipla shares trade within inches of record high; check out latest triggers for drug maker

Sat, Mar 02, 2024

Cipla share price NSE, BSE: Cipla shares looked almost prepared to register a fresh all-time high in a special session on Saturday, March 2, after the US drug regulator completed inspections at a facility of the Mumbai-headquartered pharma company's Chinese subsidiary, Cipla Jiangsu, with zero observations.

Cipla eyes acquisitions, inorganic partnerships in US market

Cipla eyes acquisitions, inorganic partnerships in US market

Sun, Feb 04, 2024

"Product launches through delisting strategy and as well as inorganic partnerships and acquisitions will remain one of our key priorities for the US market," Cipla Global Chief Financial Officer Ashish Adukia said in an analyst call.

Cipla Shares Slip as Executive Vice-Chair Steps Down | Stock Market News

Cipla Shares Slip as Executive Vice-Chair Steps Down | Stock Market News

Mon, Jan 29, 2024

Shares of Cipla dipped 3% as Samina Hamied resigned as executive vice-chair, transitioning to a non-executive director role. The move is part of a broader strategy to professionalize Cipla's management, akin to conglomerates like the Tata Group. Balram Bhargava was appointed as an additional independent director, bringing over 35 years of global public health leadership experience.

Cipla posts better-than-estimated Q3 results; stock hits all-time high

Cipla posts better-than-estimated Q3 results; stock hits all-time high

Tue, Jan 23, 2024

As of 9:56 a.m., shares of drug major Cipla traded 6.85 per cent or Rs 89.85, higher on the BSE at Rs 1,402.45 apiece. The market capitalisation of the company at around the same time stood at Rs 1,13,227.87 crore.

Cipla Q3 results: 32% rise in net profit to Rs 1,056 crore

Cipla Q3 results: 32% rise in net profit to Rs 1,056 crore

Mon, Jan 22, 2024

The Mumbai-based company had posted a consolidated net profit of Rs 801 crore in the year-ago period, Cipla Ltd said in a statement. Total revenue from operations in the third quarter of the current fiscal rose to Rs 6,604 crore as compared with Rs 5,810 crore in the year-ago period.

Load More

LIVE TV

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x